Clinical Trial Update: Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating post-TIPS albumin infusion to prevent hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Albumin

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED